CollPlant Closes $3.7 Million Private Placement

CollPlant Biotechnologies closed a private placement on October 14, 2026, with expected gross proceeds of approximately $3.7 million. The offering comprised 989,301 ordinary shares or pre-funded warrants in lieu thereof, with accompanying ordinary warrants. The combined purchase price was $3.74 per ordinary share with accompanying warrants, or $3.7499 per pre-funded warrant with accompanying warrants. Ordinary warrants cover up to 1,483,950 shares at a $3.74 exercise price, expiring five years following registration statement effectiveness. Net proceeds will fund general corporate purposes, including working capital and research and development programs. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Collplant Biotechnologies Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref